LO COCO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1.048
EU - Europa 325
AS - Asia 226
SA - Sud America 11
AF - Africa 3
OC - Oceania 1
Totale 1.614
Nazione #
US - Stati Uniti d'America 1.035
IT - Italia 93
SG - Singapore 91
SE - Svezia 88
CN - Cina 72
IN - India 59
FI - Finlandia 31
UA - Ucraina 24
DE - Germania 20
BG - Bulgaria 15
GB - Regno Unito 14
CA - Canada 13
RO - Romania 11
BE - Belgio 9
AR - Argentina 8
RU - Federazione Russa 8
IE - Irlanda 6
CL - Cile 3
FR - Francia 3
TG - Togo 2
AT - Austria 1
EE - Estonia 1
HK - Hong Kong 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
NZ - Nuova Zelanda 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 1.614
Città #
Fairfield 150
Woodbridge 87
Chandler 82
Houston 66
Ashburn 64
Singapore 63
Cambridge 60
Wilmington 53
Seattle 52
Santa Clara 49
Princeton 45
Beijing 37
Plano 31
San Paolo di Civitate 29
Rome 24
Ann Arbor 23
Boston 19
Des Moines 16
Lawrence 16
Sofia 15
Brussels 9
Millbury 9
San Diego 9
Andover 8
Dearborn 8
Federal 8
Florence 8
Toronto 7
Trento 7
Dublin 6
Jacksonville 6
Falkenstein 5
Kunming 5
Norwalk 5
Ottawa 5
Bühl 4
Hefei 4
Helsinki 4
Nanjing 4
Boardman 3
Bologna 3
Bolzano Vicentino 3
Moscow 3
San Cesareo 3
San Mateo 3
Southend 3
Bremen 2
Buffalo 2
Falls Church 2
Frankfurt am Main 2
Lomé 2
London 2
Mannheim 2
Provo 2
Saline 2
Shenyang 2
Alatri 1
Auburn Hills 1
Auckland 1
Brighton 1
Dortmund 1
Fremont 1
Fresno 1
Fuzhou 1
Guangzhou 1
Hyderabad 1
Istanbul 1
Jinhua 1
Jiujiang 1
Kashan 1
Kilburn 1
Las Vegas 1
Lissone 1
Los Angeles 1
Luoyang 1
Melito Di Napoli 1
Milan 1
Montesilvano Marina 1
Montreal 1
Muizenberg 1
Naples 1
Pomezia 1
Redmond 1
Sandston 1
Scuola 1
Shanghai 1
Stockholm 1
Vienna 1
Westminster 1
Wuhan 1
Yinchuan 1
Totale 1.178
Nome #
Retinoic acid receptors. From molecular mechanisms to cancer therapy 96
Absence of HHV-8 DNA sequences in malignant mesothelioma 81
Randomized Phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: Health-related quality-of-life outcomes 78
Analysis of the BCL-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's disease. 70
GIMEMA-AIEOP AIDA Protocol for the Treatment of newly diagnosed Acute Promyelocytic Leukemia (APL) in Children. 69
Late relapses in acute promyelocytic leukaemia 68
GIMEMA-AIEOP AIDA protocols for the treatment of newly diagnosed acute promyelocytic leukemia APL) in children: analysis of patients enrolled in two sequential Italian multicenter trials 58
null 55
AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation. 52
null 52
Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study 51
null 51
"Southern blot analysis as ALL-I rearrangements at chromosome 11q23 in acute leucemia" 49
AIDA: The Italian way of Treating Acute Promyelocytic Leukemia (APL). Final Act. 49
null 48
Multigenetic lesions in infant acute leukaemias: Correlations with ALL-1 gene status 41
Long-term results of the GIMEMA LAP AIDA 0493 amended protocol in elderly patients with acute promyelocytic leukemia (APL). 39
Autologous bone marrow or peripheral blood stem cell transplantation for patientys with chronic myelogenous leukemia in chronic phase. Bone Marrow Transpl,1990. 38
incidence of late relapse (> 5 years) in patients with acute promyelocytic leukemia 38
Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial 38
Distribution of TP53 mutations among acute leukemias with MLL rearrangements 37
All1 gene at chromosome 11q23 is consistently altered in acute leukemias of early infancy 35
Front-line treatment of acute promyclocytic leukemia with AIDA induction followed by risk-adapted consolidation: Results of the AIDA-2000 trial of the Italian GIMEMA group 34
null 34
Biologic and clinical significance of CD34 expression in acute promyelocytic leukemia 33
Identification of DNA Rearrangements at the Retinoic Acid Receptor-a (RAR-a) Locus in all Patients With Acute Promyelocytic Leukemia (APL) and mapping of APL Breakpoints within the RAR-a second intron 30
Valproic acid plus retinoic acid induce myeloid differentiation in chemotherapy-resistant acute myeloid leukemia patients. 29
Recidiva extramidollare mastoidea in due pazienti pediatrici con leucemia acuta promielocitica 28
Phenotypic and molecular features of acute promyelocytic leukemia patients developing retinoic acid syndrome 27
Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerasi II related secondary leukemias 26
Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias 26
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 25
Immunoglobulin heavy chain and T-cell receptor beta chain gene rearrangements in acute non lymphoid leukemia. 25
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia 25
INFECTIOUS COMPLICATIONS IN PATIENTS WITH ACUTE PROMYELOCITIC LEUKEMIA TREATED WITH THE AIDA REGIMEN 24
MLL tandem duplication in two cases of acute myelocytic leukemia with unbalanced translocations: der(16)t(11;16)(q23;p13) and der(18)t(11;18)(q22;p11.2) 19
Studio citogenetico, morfologico, immunologico e clinico di 20 casi di leucemia linfoide acuta (LLA) Philadelphia positiva (Ph+) 18
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters 16
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies 15
Fatigue in long-term survivors of acute promyelocytic leukemia (APL) and its association with other symptoms and functional limitations 12
Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy 8
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders 8
Risk-adapted treatment of acute promyelocytic leukemia: results from International Consortium for Childhood APL 5
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism 4
Totale 1.664
Categoria #
all - tutte 5.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.359


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020218 0 0 0 0 0 0 51 52 41 31 35 8
2020/202187 13 10 7 4 1 9 1 9 16 7 7 3
2021/2022298 3 17 22 19 45 6 5 29 24 30 40 58
2022/2023351 67 68 12 29 36 61 6 18 44 0 9 1
2023/2024157 22 25 4 14 17 19 4 6 0 13 11 22
2024/2025165 12 19 11 26 54 43 0 0 0 0 0 0
Totale 1.664